Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 8:09am EST - Canadian Markets open in 1 hour and 21 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
IMS Health Inc. (RX)
On Feb 9:
21.87 USD
0.00 (0.00%)
MORE ON RX
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
IMS HEALTH INC
(NYSE:RX) Delayed quote data
Last Trade:
21.87 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
21.87
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
16.50
Day's Range:
N/A - N/A
52wk Range:
11.12 - 21.90
Volume:
0
Avg Vol
(3m)
:
4,801,420
Market Cap:
3.99B
P/E
(ttm)
:
13.97
EPS
(ttm)
:
1.57
Div & Yield:
0.12 (0.55%)
1d
5d
3m
6m
1y
2y
5y
max
Free Annual Reports
Add RX to Portfolio
Download Data
HEADLINES
IMS Health 4Q profit shrinks
AP
(Tue 6:12pm)
IMS HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online
(Tue 4:25pm)
IMS Health Announces 2009 Fourth-Quarter and Full-Year Results
Business Wire
(Tue 4:21pm)
IMS HEALTH INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online
(Mon, Feb 8)
IMS Health Announces Stockholder Approval of Merger Agreement with Affiliates of TPG and CPP Investment Board
Business Wire
(Mon, Feb 8)
[$$] Lupin Gets FDA OK to Sell Generic Heart Drug
at The Wall Street Journal Online
(Mon, Feb 8)
Obama push poses threat to Goldman
at FT.com
(Sun, Feb 7)
IMS HEALTH INC Files SEC form 8-K, Other Events
EDGAR Online
(Wed, Feb 3)
EU regulators clear IMS Health sale to TPG
at Reuters
(Wed, Feb 3)
How Times Have Changed (or Not) for Deals
at The New York Times
(Mon, Feb 1)
More Headlines for RX...
ANALYST
EPS Est (next year)
(Dec-10)
:
1.56
EPS Est (in 2 years)
(Dec-11)
:
1.71
Avg Rec (current)*:
3.0
PEG Ratio:
1.75
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
IMS Health Incorporated provides business intelligence, including information, analytics, and consulting services to the pharmaceutical and healthcare industries worldwide.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices